FBIOX vs IBB

FBIOX is a mutual fund, whereas IBB is an ETF. FBIOX has a higher 5-year return than IBB (5.85% vs 3.56%). FBIOX has a higher expense ratio than IBB (0.72% vs 0.47%). Below is the comparison between FBIOX and IBB.

IBB FBIOX
Security Type ETF Mutual fund
Segment Equity: U.S. Biotech Specialty: Health
Issuer BlackRock Fidelity Investments
Net Assets $7.66B $7.08B
Expense Ratio 0.47% 0.72%
Management Style passive (index-based) active
Dividend Yield 0.13% 0.00%
Minimum Investment N/A $2,500.00
YTD Return 24.26% 31.25%
1-Year Return 9.83% 17.47%
3-Year Return 9.65% 11.25%
5-Year Return 3.56% 5.85%
10-Year Return 16.68% 18.56%

FBIOX description

The Fund seeks capital appreciation. Fidelity Management & Research normally invests in companies principally engaged in the research, development, and manufacture of various biotechnology products, services, and processes. They may also invest the assets in companies that distribute these products.

FBIOX returns

YTD Return 31.25%
1-Month Return 13.71%
3-Month Return 15.11%
1-Year Return 17.47%
3-Year Return 11.25%
5-Year Return 5.85%
10-Year Return 18.56%
FBIOX expense ratio is 0.72%.

FBIOX holdings

Top 10 Holdings (39.37% of Total Assets)

Name Symbol % Assets
AbbVie Inc ABBV 10.96%
Amgen Inc AMGN 7.04%
Vertex Pharmaceuticals Inc VRTX 4.84%
Gilead Sciences Inc GILD 3.82%
Alexion Pharmaceuticals Inc ALXN 2.65%
Neurocrine Biosciences Inc NBIX 2.27%
Alnylam Pharmaceuticals Inc ALNY 1.98%
Biogen Inc BIIB 1.98%
Sage Therapeutics Inc SAGE 1.96%
Ionis Pharmaceuticals Inc IONS 1.87%

IBB description

The Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the Nasdaq Biotechnology Index (the "Index").

IBB returns

YTD Return 24.26%
1-Month Return 11.47%
3-Month Return 16.33%
1-Year Return 9.83%
3-Year Return 9.65%
5-Year Return 3.56%
10-Year Return 16.68%
IBB expense ratio is 0.47%.

IBB holdings

Top 10 Holdings (54.15% of Total Assets)

Name Symbol % Assets
Celgene Corp CELG 8.56%
Amgen Inc AMGN 7.84%
Gilead Sciences Inc GILD 7.69%
Vertex Pharmaceuticals Inc VRTX 6.7%
Illumina Inc ILMN 5.79%
Biogen Inc BIIB 5.22%
Regeneron Pharmaceuticals Inc REGN 4.05%
Alexion Pharmaceuticals Inc ALXN 3.27%
Seattle Genetics Inc SGEN 2.53%
Incyte Corp INCY 2.5%
Follow Us